ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Serum Alkaline Phosphatase Predicts Graft Failure and Mortality in Kidney Transplant Recipients.

    Y. Kim,1 S. Park,1 S. Yang,2 H. Lee,1 Y. Kim,3 S.-K. Park,4 D. Han,3 I. Jung,5 J. Ha,6 C. Lim,7 Y. Kim,1 J. Lee.7

    1Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; 2Seoul National University Biomedical Research Institute, Seoul, Republic of Korea; 3Division of Kidney Transplantation, Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 4Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 5Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; 6Surgery, Seoul National University Hospital, Seoul, Republic of Korea; 7Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea

    Objective: Recent studies showed that high levels of serum alkaline phosphatase (ALP) are associated with all-cause or cardiovascular death among hemodialysis patients. However, there are…
  • 2017 American Transplant Congress

    Race, Admissions, and Renal Transplant Waitlisting.

    R. Lynch, R. Zhang, R. Patzer, C. Larsen, A. Adams.

    Surgery, Emory University, Atlanta, GA

    Background: We have previously shown that increased hospitalization while listed for renal transplantation is associated with excess waitlist mortality, reduced odds of transplantation, and inferior…
  • 2017 American Transplant Congress

    Landscape of Multiple Donations from a Living Donor in the US.

    A. Thomas,1 A. Massie,1 J. Garonzik-Wang,1 K. Lentine,2 M. Henderson,1 D. Segev.1

    1JHU, Baltimore; 2SLU, St. Louis

    Guidelines for uncommon forms of living donation, such as multiple donations from the same person, are lacking. To inform future practice standards, we examined the…
  • 2017 American Transplant Congress

    Characterization of a B Lymphocyte Signature Predictive of Chronic Lung Allograft Dysfunction.

    C. Brosseau,1,2 M. Durand,1,2 E. Durand,1,2 J. Loy,2 A. Foureau,2 P. Lacoste,2 P.-J. Royer,2 A. Magnan,2 S. Brouard.1

    1INSERM UMR1064, Centre de Recherche en Transplantation et, Nantes, France; 2INSERM UMR1087, Institut du Thorax, Nantes, France

    The occurrence of chronic lung allograft dysfunction (CLAD) is the main complication after lung transplantation (LT) and remains the most common cause of graft failure…
  • 2017 American Transplant Congress

    Pre-Transplant CMV-Specific T-Cell Immunity Is an Additional Independent Variable Predicting CMV Infection After Kidney Transplantation.

    E. Crespo,1 M. Jarque,1 S. Luque,1 E. Melilli,2 A. Manonelles,2 S. Gil-Vernet,2 J. Cruzado,2 J. Grinyó,2 O. Bestard.2

    1Nephrology Laboratory, IDIBELL, Barcelona, Spain; 2Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, Spain

    Background: Current pre-transplant risk stratification for Cytomegalovirus (CMV) infection is based on donor/recipient (D/R) IgG-serostatus and clinical variables such as the use of T-cell depletion…
  • 2017 American Transplant Congress

    CMV-Infected Kidney Grafts Drive the Expansion of Blood-Born CMV-Specific T-Cells Restricted by Shared HLA Molecules Through Presentation on Donor's Cells.

    P. Gatault,1,2 S. Al-Hajj,1 J. Noble,1,2 E. Chevallier,1,2 M. Piollet,1 C. Forconi,1 R. Lemoine,1 J.-M. Halimi,1,2 M. Büchler,1,2 C. Baron.1,2

    1EA 4245, François-Rabelais University, Tours, France; 2Kidney Transplantation Department, CHRU, Tours, France

    Background. Cytomegalovirus specific immune response is crucial to control CMV infection in kidney transplant recipients (KTR), in whom recipient CMV can reactivated (R+) and donor…
  • 2017 American Transplant Congress

    More Rapid Decline in Male VS Female Living Kidney Donations (LKD) Varies by Income.

    J. Lesage, J. Gill, C. Rose, Y. Joffres, J. Gill.

    UBC, Vancouver, Canada

    Reasons for the decline in LKD remain uncertain. We hypothesized that there would be a more rapid decline in male vs female LKD and that…
  • 2017 American Transplant Congress

    Personalizing Immunosuppression with Molecular Phenotyping in Pediatric Liver Transplantation.

    M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.

    Pediatric Abdominal Transplant, Children's Hospital of Pittsburgh of UPMC, Pittsburgh

    Background: Optimizing immunosuppression requires selecting an agent which can inhibit the dominant anti-rejection mechanism in individual children with liver transplantation (LTx). Extended use of steroids,…
  • 2017 American Transplant Congress

    Tacrolimus Intra-Patient Variability Determined from Daily Trough Levels in Adherent Kidney and Liver Transplant Recipients.

    A. Leino,1 T. Kaiser,1 Y. Zou,2 E. King,2 A. Vinks,2 W. Jiang,4 U. Christians,3 E. Woodle,1 R. Alloway.1

    1University of Cincinnati, Cincinnati; 2Cincinnati Children's Hospital, Cincinnati; 3University of Colorado, Denver; 4Food and Drug Administration, Silver Spring

    Drugs are classified as highly variable when intra-patient coefficient of variation (CV%) is > 30%. Tacrolimus (TAC) is characterized as highly variable often without supporting…
  • 2017 American Transplant Congress

    Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant.

    A. Vo, J. Choi, I. Kim, E. Huang, S. Louie, A. Kang, S. Williamson, K. Myers, A. Peng, R. Najjar, S. Jordan.

    Kidney Transplant, Cedars-Sinai Medical Center, LA, CA

    INTRODUCTION: ~30% of HS patients fail to respond to DES with IVIG+rituximab. IL6/IL-6R signaling is critical for B-cell differentiation to plasmablasts and IgG production. Tocilizumab…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences